Pennsylvania governor to push cannabis legalization in 2025 (Newsletter: December 17, 2024)
From toxifillers.com with love
Marijuana biz group wants to question DEA at hearings; DEA boosts DMT production; Study: Cannabis terpenes relieve pain; LSD research
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
(function() {
window.mc4wp = window.mc4wp || {
listeners: [],
forms: {
on: function(evt, cb) {
window.mc4wp.listeners.push(
{
event : evt,
callback: cb
}
);
}
}
}
})();
Your support makes Marijuana Moment possible…
BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today.
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
The National Cannabis Industry Association is asking a Drug Enforcement Administration judge to clarify whether it can cross-examine the agency during marijuana rescheduling hearings set to start next month.
Cannabis Bioscience International Holdings is asking a Drug Enforcement Administration judge for permission to include young medical cannabis patient Alexis Bortell as a witness during upcoming marijuana rescheduling hearings.
Pennsylvania Gov. Josh Shapiro (D) says he’ll again include marijuana legalization in his budget proposal next year, and several lawmakers are also discussing plans to push for the reform to be enacted in 2025.
Wisconsin’s Senate minority leader announced a plan to push for legalizing medical cannabis in 2025 now that Democrats have eliminated a Republican supermajority in the legislature.
The Drug Enforcement Administration is significantly increasing its quota for the amount of the psychedelic DMT that can be legally produced in 2025 “to support legitimate research and scientific efforts toward an FDA-approved drug product.”
A new federally funded study shows that marijuana terpenes “relieve post-operative and fibromyalgia pain” in mice.
- “These results demonstrate that the terpenes geraniol, linalool, β-caryophyllene, and α-humulene may be a viable medication for post-operative and fibromyalgia pain relief.”
Biotechnology company MindMed announced that it has begun dosing patients in the first-ever Phase 3 clinical trial of LSD—with the current study focusing on whether the psychedelic can treat generalized anxiety disorder.
/ FEDERAL
The Drug Enforcement Administration posted information about how it schedules controlled substances.
Senate Majority Leader Chuck Schumer (D-NY) dodged a question about cannabis banking legislation.
Rep. Jamal Bowman (D-NY) said during his farewell speech on the floor of the House of Representatives that it’s time to “free all marginalized people, especially those locked up on trumped up marijuana charges.”
Rep. Barbara Lee (D-CA) tweeted, “I applaud @POTUS for this significant step towards correcting the harms of a broken criminal justice system and the failed war on drugs. I look forward to seeing the Biden Administration continue to take action to correct systemic injustices.”
/ STATES
New Jersey Gov. Phil Murphy (D) granted clemency to several people with drug convictions.
Ohio Gov. Mike DeWine (D) and the Senate president discussed the prospects of legislation to restrict intoxicating hemp products.
Minnesota Gov. Tim Walz (D) spoke about the roll-out of the state’s marijuana business licensing process amid litigation.
The West Virginia Supreme Court ruled that judges can bar people from using medical cannabis as a condition of probation.
Colorado regulators posted guidance for psychedelics businesses.
Kentucky regulators held a lottery for medical cannabis dispensary licenses.
New York regulators are providing workforce development assistance for justice-impacted cannabis entrepreneurs.
The California Cannabis Advisory Committee will meet on Wednesday.
—
Marijuana Moment is tracking more than 1,500 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The New Castle County, Delaware Council approved marijuana business zoning rules.
/ INTERNATIONAL
Canada’s minister of diversity, inclusion and persons with disabilities dodged a question about drug decriminalization.
A Philippine lawmaker said the bloody “war on drugs” waged during the administration of former President Rodrigo Duterte was a “grand criminal enterprise.”
/ SCIENCE & HEALTH
A review “provides a comprehensive overview of the current clinical evidence on medical cannabis, highlighting its potential therapeutic benefits across a range of health conditions and emphasizing the need for further high-quality research.”
/ ADVOCACY, OPINION & ANALYSIS
The Construction Financial Management Association will host an event about the impact of marijuana legalization on the construction industry on January 15.
/ BUSINESS
Rebel Rabbit announced an agreement with 24 Anheuser-Busch wholesalers to distribute its products in 30 new markets.
Innovative Industrial Properties, Inc. announced a quarterly dividend of $1.90 per share.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
(function() {
window.mc4wp = window.mc4wp || {
listeners: [],
forms: {
on: function(evt, cb) {
window.mc4wp.listeners.push(
{
event : evt,
callback: cb
}
);
}
}
}
})();
Photo courtesy of Chris Wallis // Side Pocket Images.
The post Pennsylvania governor to push cannabis legalization in 2025 (Newsletter: December 17, 2024) appeared first on Marijuana Moment.